Page last updated: 2024-12-08
aminobenzyl-edta
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
aminobenzyl-EDTA: RN given refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 134715 |
| CHEMBL ID | 81013 |
| SCHEMBL ID | 1742184 |
| MeSH ID | M0161280 |
Synonyms (16)
| Synonym |
|---|
| CHEMBL81013 |
| glycine, n,n'-(1-((4-aminophenyl)methyl)-1,2-ethanediyl)bis(n-(carboxymethyl)- |
| aminobenzyl-edta |
| 84256-90-6 |
| 2,2',2'',2'''-{[3-(4-aminophenyl)propane-1,2-diyl]dinitrilo}tetraacetic acid |
| 2-[[3-(4-aminophenyl)-2-[bis(carboxymethyl)amino]propyl]-(carboxymethyl)amino]acetic acid |
| FT-0648726 |
| AKOS015889513 |
| SCHEMBL1742184 |
| RPBJIOJIMOUOIN-UHFFFAOYSA-N |
| 1-(p-aminobenzyl)ethylenediaminetetraacetic acid |
| 1-(4-aminobenzyl)ethylenediamine-n,n,n',n'-tetraacetic acid |
| aminobenzyl-edta, >=90% (chn) |
| 2,2',2'',2'''-(3-(4-aminophenyl)propane-1,2-diyl)bis(azanetriyl)tetraacetic acid |
| DTXSID301004541 |
| 2-{[1-(4-aminophenyl)-3-[bis(carboxymethyl)amino]propan-2-yl](carboxymethyl)amino}acetic acid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (7)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID26719 | Biodistribution of labeled B72.3-chelator conjugate(EDTA isothiocynates) in Nude mice bearing LS174T tumors, in spleen, administered intravenously expressed as % of injected dose of indium-111 per gram of tissue | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting. |
| AID26718 | Biodistribution of labeled B72.3-chelator conjugate(EDTA isothiocynates) in Nude mice bearing LS174T tumors, in lungs, administered intravenously expressed as % of injected dose of indium-111 per gram of tissue | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting. |
| AID26504 | Biodistribution of labeled B72.3-chelator conjugate (EDTA isothiocynates) in Nude mice bearing LS174T tumor (Ag-), administered intravenously; ND is no data. | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting. |
| AID26505 | Biodistribution of labeled B72.3-chelator conjugate (EDTA isothiocynates) in Nude mice bearing LS174T tumors, in blood, administered intravenously expressed as % of injected dose of indium-111 per gram of tissue | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting. |
| AID26721 | Biodistribution of labeled B72.3-chelator conjugatec in Nude mice bearing LS174T tumor (Ag+), administered intravenously expressed as % of injected dose of indium-111 per gram of tissue | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting. |
| AID26720 | Biodistribution of labeled B72.3-chelator conjugate(EDTA isothiocynates) in nude mice bearing LS174T tumors, in kidney, administered intravenously expressed as % of injected dose of indium-111 per gram of tissue | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting. |
| AID26717 | Biodistribution of labeled B72.3-chelator conjugate(EDTA isothiocynates) in Nude mice bearing LS174T tumors, in liver, administered intravenously expressed as % of injected dose of indium-111 per gram of tissue | 1989 | Journal of medicinal chemistry, Jan, Volume: 32, Issue:1 | Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.51
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.51) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||